Sara K. Vesely, Ph.D.

Phone: (405) 271-2229, x48069 

Office: Hudson College of Public Health 

801 NE 13th St, Room 358  

Post Office Box 26901 

Oklahoma City, OK 73126-0901 

Email: Sara-Vesely@ouhsc.edu 

Sara Vesely is a David Ross Boyd Professor in the Department of Biostatistics and Epidemiology, and Associate Dean for Academic Affairs, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK. She is also the Director of the Biostatistics Core at the Stephenson Cancer Center. Her research interests include clinical trial methodology, frequency data, hematological disorders, and youth assets.  As part of her teaching responsibilities, Dr. Vesely has taught clinical trial, analysis of frequency data, and other methodological courses in the Department of Biostatistics and Epidemiology. Dr. Vesely also is the Director of the Summer Undergraduate Research Programs and Director of the Master of Science in Clinical and Translational Sciences Program which are both housed in the Graduate College. She is the Co-Director of the Oklahoma Shared Clinical and Translational Resource funded Translating Practice Into Research Program.

Education 

• PhD, Biostatistics, University of Oklahoma Health Sciences Center, 1998 
• MPH, Biostatistics, University of Oklahoma Health Sciences Center, 1994 
• BA, Mathematics, University of Oklahoma, 1993

Appointments 

• Professor, Hudson College of Public Health, OUHSC, 2010 - present 
• Associate Professor, Hudson College of Public Health, OUHSC, 2005–2010 
• Assistant Professor, Hudson College of Public Health, OUHSC, 2002–2005 
• Assistant Professor of Research, Hudson College of Public Health, OUHSC, 1999–2002 

Research Interests: 

• Thrombotic thrombocytopenic purpura – hemolytic uremic syndrome (TTP-HUS) 
• Immune thrombocytopenic purpura (ITP) 
• Youth assets 
• Clinical trial design 
• Hematological malignancies 

Link to Dr. Vesely's current publications

Select publications 

1. Maiti, Guru; Sinha, Sutapa; Mahmud, Hasan; Boysen, Justin; Mendez, Mariana; Vesely, Sara; Holter-Chakrabarty, Jennifer; Kay, Neil; Ghosh, Asish. SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis. Blood Cancer J. 2021;11(5):93. doi:10.1038/s41408-021-00484-6 

2. Wiercioch, Wojtek; Nieuwlaat, Robby; Dahm, Philipp; Iorio, Alfonso; Mustafa, Reem; Neumann, Ignacio; Rochwerg, Bram; Manja, Veena; Alonso-Coello, Pablo; Ortel, Thomas; Santesso, Nancy; Vesely, Sara; Akl, Elie; Schunemann, Holger; Bates, Shannon; Cuker, Adam; Lim, Wendy; Monagle, Paul; Kunkle, Robert; Witt, Daniel; Kahn, Susan; McLintock, Claire; Rezende, Suely; Zakai, Neil; ASH VTE Panels Working Group. Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines [published online ahead of print, 2021 May 13]. J Clin Epidemiol. 2021;S0895-4356(21)00139-6. doi:10.1016/j.jclinepi.2021.04.016 

3. Denson, Lindsay; Terrell, Deirdra; Vesely, Sara; Peck, Jennifer; Quiroz, Lieschen; Shobeiri, Abbas. The Prevalence of Pelvic Floor Hematoma After Vaginal Delivery. Female Pelvic Med Reconstr Surg. 2021;27(6):393-397. doi:10.1097/SPV.0000000000000895  

4. Zheng, X.; Vesely, Sara; Cataland, Spero; Coppo, Paul; Geldziler, Brian; Iorio, Alfonso; Matsumoto, Masanori; Mustafa, Reem; Pai, Menaka; Rock, Gail; Russell, Lene; Tarawneh, Rawan; Valdes, Julie; Peyvandi, Flora. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura . J Thromb Haemost. 2020;18(10):2486-2495. doi:10.1111/jth.15006 

5. Zheng, X.; Vesely, Sara; Cataland, Spero; Coppo, Paul; Geldziler, Brian; Iorio, Alfonso; Matsumoto, Masanori; Mustafa, Reem; Pai, Menaka; Rock, Gail; Russell, Lene; Tarawneh, Rawan; Valdes, Julie; Peyvandi, Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020;18(10):2503-2512. doi:10.1111/jth.15009